(acromegaly or Cushing’s syndrome) ( 5 , 6 , 7 ); however, posterior pituitary dysfunction (diabetes insipidus (DI)) is virtually never seen prior to surgery ( 4 ). PPTs are usually seen as suprasellar or sellar-suprasellar masses with no pathognomonic
Search Results
Liza Das, Kim Vaiphei, Ashutosh Rai, Chirag Kamal Ahuja, Paramjeet Singh, Ishani Mohapatra, Rajesh Chhabra, Anil Bhansali, Bishan Dass Radotra, Ashley B Grossman, Márta Korbonits, and Pinaki Dutta
Reem Al Argan, Abdulaziz Ramadhan, Ramanakumar V Agnihotram, Jeffrey Chankowsky, and Juan Rivera
Bonneville JF . T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective . Pituitary 2017 20 116 – 120 . ( https://doi.org/10.1007/s11102-017-0788-8 ) 16 Mukai K
Kennett Sprogøe, Eva Mortensen, David B Karpf, and Jonathan A Leff
regurgitant valvular heart disease in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 71 – 75 . ( doi:10.1210/jc.2003-030849 ) 10.1210/jc.2003-030849 52 Melmed S. Acromegaly pathogenesis and treatment. Journal of Clinical
Filippo Ceccato, Elisa Selmin, Chiara Sabbadin, Miriam Dalla Costa, Giorgia Antonelli, Mario Plebani, Mattia Barbot, Corrado Betterle, Marco Boscaro, and Carla Scaroni
Endocrinology and Metabolism 2016 101 3888 – 3921 . ( https://doi.org/10.1210/jc.2016-2118 ) 10.1210/jc.2016-2118 4 Ceccato F Lizzul L Zilio M Barbot M Denaro L Emanuelli E Alessio L Rolma G Manara R Saller A , et al . Medical treatment for acromegaly
M Boering, P R van Dijk, S J J Logtenberg, K H Groenier, B H R Wolffenbuttel, R O B Gans, N Kleefstra, and H J G Bilo
, elevated androgen levels, alopecia, acromegaly, hypothyroidism, hyperthyroidism, liver cirrhosis, and use of oral contraceptive or anti-epileptic drugs were excluded. Measurements The following data were recorded at baseline: smoking, alcohol
Roxanne C S van Adrichem, Aart Jan van der Lely, Martin Huisman, Piet Kramer, Richard A Feelders, Patric J D Delhanty, and Wouter W de Herder
following: past or existent malignancies; endocrine disorders including diabetes mellitus, acromegaly, Cushing syndrome; metabolic syndrome; any active use of glucocorticoids; active inflammatory or infectious disease; past gastric surgery, kidney, or liver
Marcus Quinkler, Bertil Ekman, Claudio Marelli, Sharif Uddin, Pierre Zelissen, Robert D Murray, and on behalf of the EU-AIR Investigators
Sheppard MC Hawkins MM Bates AS Stewart PM. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly . Journal of Clinical Endocrinology and Metabolism
David J F Smith, Hemanth Prabhudev, Sirazum Choudhury, and Karim Meeran
deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly . Journal of Clinical Endocrinology and Metabolism 2009 94 4216 – 4223 . ( doi:10.1210/jc.2009-1097 ) 10
Elena Pardi, Stefano Mariotti, Natalia S Pellegata, Katiuscia Benfini, Simona Borsari, Federica Saponaro, Liborio Torregrossa, Antonello Cappai, Chiara Satta, Marco Mastinu, Claudio Marcocci, and Filomena Cetani
transfected with sequence encoding the W76X nonsense variant found in the first MEN4 patient, affected by PHPT and acromegaly (7) . Notably, both the S125X and the W76X mutations have previously been detected in a somatic setting in a small intestine NET (SI
Giovanni Tulipano
directions . CNS Oncology 2015 411 – 429 . ( https://doi.org/10.2217/cns.15.21 ) 94 Giustina A Mazziotti G Torri V Spinello M Floriani I Melmed S. Metanalysis on the effects of octreotide on tumor mass in acromegaly . PLoS ONE 2012 e
